PGEN Stock: Price, Earnings History and SEC Filings
Precigen, Inc. (PGEN) last traded at $6.94, up 4.52% on the latest session and down 18.9% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $0.05 against an analyst estimate of $-0.02, a beat of 350.0%.
$6.94 +4.52%
1 month-18.93%
52-week high$8.98
52-week low$3.04
Volume8.10M
ExchangeNasdaqGS
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
PGEN earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 4, 2026 | $0.05 | $-0.02 | +350.00% |
| Mar 2026 | May 13, 2026 | $-0.02 | $-0.03 | +33.33% |
| Dec 2025 | Mar 25, 2026 | $-0.01 | $-0.10 | +90.00% |
| Sep 2025 | Nov 13, 2025 | $-0.11 | $-0.08 | -37.50% |
PGEN beat the analyst EPS estimate in 3 of its last 4 reported quarters. Source: Nasdaq.
Latest SEC filings for PGEN
SEC filing data is not available right now. You can search for PGEN on SEC EDGAR.
PGEN news
- PGEN Stock Craters 27% After-Hours After Rival Inovio's Rare Disease Drug Receives FDA ApprovalOct 30, 2026 · stocktwits.com
- C4 Therapeutics, Inc. (CCCC) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 ReleaseOct 29, 2026 · finance.yahoo.com
- Precigen to Announce Third Quarter 2026 Financial Results and Provide Business Updates on November 4Oct 28, 2026 · finance.yahoo.com
- Precigen (PGEN) Stock May Be Fully Priced On Its Huge 3 Year RunOct 20, 2026 · finance.yahoo.com
About Precigen, Inc.
Precigen, Inc. (PGEN) is a US-listed public company on Nasdaq.